Tsuruta A, Yamashita K, Tanioka H, Tsuji A, Inukai M, Yamakawa T, . . . Okajima M. (2016). Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study. Dove Medical Press.
Chicago Style (17th ed.) CitationTsuruta A, et al. Feasibility of Sequential Adjuvant Chemotherapy with a 3-month Oxaliplatin-based Regimen Followed by 3 Months of Capecitabine in Patients with Stage III and High-risk Stage II Colorectal Cancer: JSWOG-C2 Study. Dove Medical Press, 2016.
MLA (9th ed.) CitationTsuruta A, et al. Feasibility of Sequential Adjuvant Chemotherapy with a 3-month Oxaliplatin-based Regimen Followed by 3 Months of Capecitabine in Patients with Stage III and High-risk Stage II Colorectal Cancer: JSWOG-C2 Study. Dove Medical Press, 2016.